IDEXX Laboratories Inc at Raymond James Institutional Investors Conference Transcript
Good morning. I'm Andrew Cooper, part of the animal health research team here at Raymond James. I'm going to be quick here because I've been told that Jay's presentation is 29 minutes and 45 seconds. But we're excited to have IDEXX here, leading player in animal health diagnostics markets, fast-growing market and a business that's really been able to outpace that market and drive a lot of the, frankly, market growth as well with nice margin expansion as well and a 15% to 20% EPS growth goal long term that trying to think any time there's been a slip on that and can't come up with one.
So with that, I'll leave it to Jay.
Thank you, Andrew, and good morning. I'd like to welcome everybody to a strategic overview of IDEXX. I'm Jay Mazelsky, I'm CEO of IDEXX. I'd like to welcome everybody here in the room as well as those participating in the webcast.
I'd also like
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
